Terazosin is a medication used in the management and treatment of benign prostatic hyperplasia and essential hypertension. Terazosin is a long-acting, selective alpha-1 adrenergic receptor antagonist. This activity reviews the indications, action, and contraindications for Terazosin as a valuable agent in managing benign prostatic hyperplasia, essential hypertension, and nephrolithiasis.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit
MOC types
ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABA — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Cross-Specialty
Relevant across 8 specialties.
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Blood Banking & Transfusion Medicine
- Brain Injury Rehabilitation
- Breast Imaging
- Cardiac Anesthesia
- Cardiothoracic Surgery
- Cardiovascular Disease
- Chemical Pathology
- Clinical Cardiac Electrophysiology
- Clinical Informatics
- Critical Care Medicine
- Cytopathology
- Dermatopathology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Foot & Ankle Surgery
- Forensic Pathology
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Head & Neck Surgery
- Hematology
- Hematopathology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Cardiology
- Interventional Radiology
- Laryngology
- Medical Leadership & Administration
- Medical Microbiology
- Medical Oncology
- Medical Toxicology
- Metabolic & Bariatric Surgery
- Molecular Genetic Pathology
- Musculoskeletal Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neuro Anesthesia
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurological & Spinal Cord Injury Rehab
- Neuromuscular Medicine
- Neuropathology
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Sports Medicine
- Orthopaedic Surgery
- Orthopaedic Trauma
- Otology & Neurotology
- Pain Medicine
- Patient Safety & Quality Improvement
- Pediatric Anesthesia
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Orthopaedic Surgery
- Pediatric Otolaryngology
- Pediatric Pathology
- Pediatric Radiology
- Pediatric Rehabilitation Medicine
- Pediatric Surgery
- Pediatric Transplant Hepatology
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Rhinology
- Shoulder & Elbow Surgery
- Sleep Medicine
- Spine Surgery
- Surgery of the Hand & Upper Extremity
- Surgical Critical Care
- Surgical Oncology
- Thoracic Anesthesia
- Thoracic Surgery
- Transplant Hepatology
- Transplant Surgery
- Trauma Surgery
- Urology
- Vascular Neurology
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- Article / monograph / reference
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Fee varies · this provider typically $49–98
-
ReleasedSep 1, 2026
-
Last day to claim creditSep 1, 2029 3 years left
